Standout Papers
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma (2002)
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte (2010)
- Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study (2017)
Immediate Impact
4 by Nobel laureates 11 from Science/Nature 79 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Works of Éric Van Den Neste being referenced
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
2018
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Éric Van Den Neste | 5335 | 1918 | 4120 | 45 | 7.0k | |
| Félix Reyes | 5367 | 2067 | 3641 | 55 | 7.3k | |
| P Lederlin | 5002 | 1986 | 3209 | 76 | 6.3k | |
| Richard Klasa | 5680 | 2344 | 3964 | 104 | 7.3k | |
| Mukesh Chhanabhai | 4681 | 1403 | 2898 | 48 | 5.5k | |
| ML Cleary | 4955 | 2084 | 3111 | 49 | 7.5k | |
| Réda Bouabdallah | 5579 | 2301 | 4225 | 124 | 8.0k | |
| Hans Hagberg | 3961 | 1782 | 3064 | 136 | 6.2k | |
| Michele Ghielmini | 6279 | 2971 | 4442 | 134 | 8.6k | |
| F Reyes | 3388 | 1513 | 2278 | 62 | 4.8k | |
| Jan Walewski | 4453 | 1855 | 4145 | 207 | 6.8k |
All Works
Loading papers...